Literature DB >> 18474248

The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus.

Jiang Qian1, Amod A Sarnaik, Tera M Bonney, Jeremy Keirsey, Kelly A Combs, Kira Steigerwald, Samir Acharya, Gregory K Behbehani, Michelle C Barton, Andrew M Lowy, Joanna Groden.   

Abstract

BACKGROUND & AIMS: The APC tumor suppressor is well known for its ability to regulate Wnt signaling through mediation of beta-catenin levels in the cell. Transient over expression of the tumor suppressor gene APC in colon cancer cells prevents entry into S phase of the cell cycle, a phenotype only partially restored by cotransfection of a transcriptionally active form of beta-catenin. In an attempt to define its transcription-independent tumor suppressor functions, we tested whether APC directly affects DNA replication.
METHODS: A transcriptionally quiescent in vitro DNA replication system, the polymerase chain reaction, DNA binding assays, and transient transfections in colon cancer cell lines were used to determine the effects of APC on DNA replication and the mechanism by which it works.
RESULTS: We report that exogenous full-length APC inhibits replication of template DNA through a function that maps to amino acids 2140-2421, a region of the protein commonly lost by somatic or germline mutation. This segment of APC directly interacts with DNA, while mutation of the DNA-binding S(T)PXX motifs within it abolishes DNA binding and reduces inhibition of DNA replication. Phosphorylation of this segment by cyclin-dependent kinases also reduces inhibition of DNA replication. Furthermore, transient transfection of an APC segment encoding amino acids 2140-2421 into a colon cancer cell line with mutant APC prevents cell cycle progression into or through S phase.
CONCLUSIONS: Our results suggest that APC can negatively regulate cell cycle progression through inhibition of DNA replication by direct interaction with DNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18474248      PMCID: PMC2832605          DOI: 10.1053/j.gastro.2008.03.074

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  44 in total

1.  In vitro reconstitution of nuclei for replication and transcription.

Authors:  A J Crowe; M C Barton
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  EB1, a protein which interacts with the APC tumour suppressor, is associated with the microtubule cytoskeleton throughout the cell cycle.

Authors:  E E Morrison; B N Wardleworth; J M Askham; A F Markham; D M Meredith
Journal:  Oncogene       Date:  1998-12-31       Impact factor: 9.867

3.  Human protein tau represses DNA replication in vitro.

Authors:  Wen Li; Xing Sheng Wang; M H Qu; Ying Liu; Rong Qiao He
Journal:  Biochim Biophys Acta       Date:  2005-09-27

4.  The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Authors:  H C Crawford; B M Fingleton; L A Rudolph-Owen; K J Goss; B Rubinfeld; P Polakis; L M Matrisian
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

5.  The APC protein binds to A/T rich DNA sequences.

Authors:  J Deka; P Herter; M Sprenger-Haussels; S Koosch; D Franz; K M Müller; C Kuhnen; I Hoffmann; O Müller
Journal:  Oncogene       Date:  1999-10-07       Impact factor: 9.867

6.  Redefining the subcellular location and transport of APC: new insights using a panel of antibodies.

Authors:  Mariana Brocardo; Inke S Näthke; Beric R Henderson
Journal:  EMBO Rep       Date:  2005-02       Impact factor: 8.807

7.  The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF.

Authors:  Fumihiko Hamada; Mariann Bienz
Journal:  Dev Cell       Date:  2004-11       Impact factor: 12.270

8.  Caspase cleavage of the APC tumor suppressor and release of an amino-terminal domain is required for the transcription-independent function of APC in apoptosis.

Authors:  J Qian; K Steigerwald; K A Combs; M C Barton; J Groden
Journal:  Oncogene       Date:  2007-02-05       Impact factor: 9.867

9.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

10.  The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.

Authors:  Jose Sierra; Tomonori Yoshida; Claudio A Joazeiro; Katherine A Jones
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

View more
  19 in total

Review 1.  Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis.

Authors:  Satya Narayan; Ritika Sharma
Journal:  Life Sci       Date:  2015-09-01       Impact factor: 5.037

Review 2.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

Review 3.  Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.

Authors:  William Hankey; Wendy L Frankel; Joanna Groden
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

4.  Assembly of the base excision repair complex on abasic DNA and role of adenomatous polyposis coli on its functional activity.

Authors:  Aruna S Jaiswal; Satya Narayan
Journal:  Biochemistry       Date:  2011-02-04       Impact factor: 3.162

5.  Colorectal cancer: the APC-lncRNA link.

Authors:  Pat J Morin
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

6.  Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin.

Authors:  Kari N Nejak-Bowen; Michael D Thompson; Sucha Singh; William C Bowen; Mohd Jamal Dar; Jaspal Khillan; Chunsun Dai; Satdarshan P S Monga
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

7.  A pilot study evaluating genetic alterations that drive tobacco- and betel quid-associated oral cancer in Northeast India.

Authors:  Dhirendra Singh Yadav; Indranil Chattopadhyay; Anand Verma; Thoudam Regina Devi; L C Singh; Jagannath Dev Sharma; Amal Ch Kataki; Sunita Saxena; Sujala Kapur
Journal:  Tumour Biol       Date:  2014-06-19

Review 8.  Interaction between APC and Fen1 during breast carcinogenesis.

Authors:  Satya Narayan; Aruna S Jaiswal; Brian K Law; Mohammad A Kamal; Arun K Sharma; Robert A Hromas
Journal:  DNA Repair (Amst)       Date:  2016-04-07

Review 9.  β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.

Authors:  Satdarshan Pal Monga
Journal:  Gastroenterology       Date:  2015-03-05       Impact factor: 22.682

10.  APC is an RNA-binding protein, and its interactome provides a link to neural development and microtubule assembly.

Authors:  Nicolas Preitner; Jie Quan; Dan W Nowakowski; Melissa L Hancock; Jianhua Shi; Joseph Tcherkezian; Tracy L Young-Pearse; John G Flanagan
Journal:  Cell       Date:  2014-07-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.